Chronic myringitis

H8_MYRINGCHRON

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H73.1
  • Hospital discharge: ICD-9 3841
  • Cause of death: ICD-10 H73.1
  • Cause of death: ICD-9 3841

2 out of 7 registries used, show all original rules.

167

4. Check minimum number of events

None

167

5. Include endpoints

None

167

6. Filter based on genotype QC (FinnGen only)

167

Control definitions (FinnGen only)

Control exclude
H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H73
Name in latin
Myringitis chronica

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1468 726 734
Only index persons 1375 692 683
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.02
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 43.87 44.67 43.07
Only index persons 44.96 45.66 44.24

-FinnGen-

Key figures

All Female Male
Number of individuals 167 89 78
Unadjusted period prevalence (%) 0.03 0.03 0.03
Median age at first event (years) 55.85 55.17 56.62

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
145
Matched controls
1450
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H73.1
ICD-10 Finland
Chronic myringitis
+∞
203.5
143
*
UDC00
NOMESCO Finland
Ear microscopy
62.5
79.1
93
40
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
1118.1
71.5
64
*
DCD00
NOMESCO Finland
Myringoplasty
+∞
44.0
40
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
25.3
32.4
46
26
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
299.5
25.5
25
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
299.5
25.5
25
*
H66.9
ICD-10 Finland
Otitis media, unspecified
19.3
25.3
39
27
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
+∞
21.4
20
*
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
47.4
20.2
24
6
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
216.9
19.0
19
*
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
+∞
18.1
17
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
11.5
17.4
33
36
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
40.5
17.2
21
6
DC1AD
NOMESCO Finland
Temporalbone CT
191.1
16.9
17
*
H04
ICPC
Ear discharge
20.2
16.3
24
14
S02CA02
ATC
flumetasone and antiinfectives; otic
11.9
16.2
30
31
H60.8
ICD-10 Finland
Other otitis externa
30.4
16.1
21
8
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.0
14.6
44
98
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
+∞
13.8
13
*
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
153.8
13.7
14
*
H01
ICPC
Ear pain/earache
6.3
12.5
35
70
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
3.6
12.0
73
315
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
70.8
11.8
13
*
H65.2
ICD-10 Finland
Chronic serous otitis media
+∞
11.6
11
*
H60.3
ICD-10 Finland
Other infective otitis externa
22.2
11.4
16
8
TDA90
NOMESCO Finland
Removal wax from ear
47.3
11.1
13
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.6
11.1
42
118
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.6
10.6
61
246
DFF00
NOMESCO Finland
Pure tone audiometry
5.7
10.5
31
66
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.1
9.8
92
519
H71
ICD-10 Finland
Cholesteatoma of middle ear
+∞
9.5
9
*
DCD10
NOMESCO Finland
Tympanoplasty
+∞
9.5
9
*
H74.1
ICD-10 Finland
Adhesive middle ear disease
+∞
9.5
9
*
WX720
NOMESCO Finland
Own respiration
8.0
9.4
21
30
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
39.3
9.2
11
*
SPAT1044
SPAT
Tympanometry
20.2
9.1
13
7
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
29.5
8.6
11
*
DCW99
NOMESCO Finland
Other operation on eardrum and middle ear
+∞
8.4
8
*
H70.1
ICD-10 Finland
Chronic mastoiditis
+∞
8.4
8
*
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
+∞
8.4
8
*
H73.0
ICD-10 Finland
Acute myringitis
47.6
7.8
9
*
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
84.2
7.5
8
*
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
+∞
7.3
7
*
H65.0
ICD-10 Finland
Acute serous otitis media
31.7
7.2
9
*
H71
ICPC
Acute otitis media/myringitis
31.7
7.2
9
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
7.7
7.2
16
23
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
10.9
7.2
13
13
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
11.8
6.9
12
11
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
42.1
6.8
8
*
4122
FHL
Tympanostomy (tympanic tube)
72.9
6.5
7
*
WX704
NOMESCO Finland
Intubation
4.5
6.4
22
55
H72.8
ICD-10 Finland
Other perforations of tympanic membrane
+∞
6.3
6
*
DCA40
NOMESCO Finland
Fat patching or other similar technique without opening of tympanic membrane
+∞
6.3
6
*
H60
ICD-10 Finland
Otitis externa
6.3
6.0
15
26

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
63
151
6.09
26.89
2.2
1.7
—
—
—
0
0
34
86
4.71
12.93
2.5
2.5
54.9
166.1
ng/l
2.53
29
78
46
176
3.23
9.54
1.7
1.5
—
—
—
0
0
42
191
2.60
6.14
1.8
2.1
—
—
—
0
0
22
73
3.32
5.62
3.0
18.2
—
—
—
0
0
47
239
2.35
5.35
2.4
3.4
111.5
102.4
ng/l
0.04
29
178
55
305
2.20
5.07
3.7
3.6
1.0
1.0
kg/l
0.82
11
41
122
920
2.21
4.94
4.5
4.1
—
—
—
0
0
133
1046
2.33
4.74
4.2
3.9
14.8
14.7
pmol/l
0.15
121
934
65
407
1.98
4.22
3.7
4.0
4.0
11.2
mg/mmol
1.39
36
247
66
421
1.94
4.02
2.9
3.1
7.5
7.5
mmol/l
0.03
58
353
105
781
1.93
4.00
3.8
5.9
7.0
6.8
mmol/l
0.27
90
728
131
1059
2.10
3.83
6.0
7.8
72.8
79.3
u/l
1.54
122
991
60
384
1.88
3.54
3.1
3.3
1462.2
245.3
mg/l
0.40
32
243
75
530
1.75
3.12
8.0
9.4
1.1
1.2
inr
1.64
17
166
116
937
1.78
2.93
4.0
3.8
—
—
—
0
0
145
1269
2.08
2.68
5.4
4.6
1.9
1.9
mu/l
0.09
136
1152
24
123
2.11
2.61
1.8
2.1
413.5
399.8
nmol/l
0.13
24
112
45
291
1.75
2.47
1.7
1.6
143243632.8
469.4
pmol/l
0.49
37
250
57
399
1.65
2.33
1.6
2.1
109.6
158.2
u/l
1.94
51
380
75
563
1.60
2.31
3.6
5.3
36.6
35.7
g/l
0.78
67
531
19
347
0.49
2.29
2.6
3.8
90.7
90.1
%
0.03
19
339
108
886
1.62
2.28
3.5
4.1
—
14.4
—
0
12
153
1389
2.21
2.19
11.0
13.9
21.0
22.7
mg/l
0.25
126
1074
22
118
2.00
2.14
1.1
1.2
—
—
—
0
0
66
496
1.55
1.95
2.2
1.9
95.6
94.4
pmol/l
0.08
37
254
35
235
1.62
1.65
1.5
1.7
1014.5
1214.9
nmol/l
0.95
30
185
15
78
2.01
1.60
3.1
3.8
4.6
4.5
pmol/l
0.18
15
68
12
57
2.19
1.59
1.2
1.1
—
—
—
0
0
47
620
0.66
1.57
9.6
9.1
0.0
0.0
e9/l
0.91
40
502
142
1292
1.66
1.54
14.6
14.8
39.9
40.1
%
0.07
71
966
0
45
0.00
1.52
0.0
3.2
—
—
—
0
0
86
709
1.44
1.52
5.5
6.9
9.9
11.6
umol/l
1.98
80
679
56
426
1.47
1.51
2.2
2.9
56.0
55.9
u/l
0.01
50
397
22
137
1.70
1.38
1.6
1.8
—
—
—
0
0
0
38
0.00
1.36
0.0
1.1
—
—
—
0
0
52
400
1.44
1.30
2.9
3.7
7.4
7.4
ph
—
9
70
145
1340
1.62
1.30
5.3
4.4
6.1
5.9
mmol/l
0.76
134
1237
58
457
1.41
1.27
3.9
5.1
—
—
—
0
0
6
25
2.45
1.25
1.2
1.6
—
—
—
0
0
149
1389
1.67
1.25
5.5
4.9
2.7
2.8
mmol/l
0.56
135
1282
33
234
1.51
1.24
1.3
1.3
1.1
6.2
u/ml
—
10
85
147
1367
1.63
1.23
4.9
4.4
4.5
4.6
mmol/l
0.61
137
1271
16
94
1.78
1.22
1.3
1.1
53.8
198.0
iu/ml
2.17
11
35
27
381
0.65
1.21
2.0
2.7
—
—
—
0
0
80
670
1.37
1.21
3.9
3.5
0.0
0.0
estimate
—
8
134
11
57
2.00
1.20
1.9
2.5
—
—
—
0
0
14
227
0.58
1.13
1.8
3.2
2.5
2.5
mmol/l
0.48
14
194
138
1273
1.48
1.12
6.5
5.6
40.7
39.9
mmol/mol
0.43
128
1191
26
179
1.54
1.11
1.3
1.3
440.0
417.7
titre
—
6
43
62
508
1.35
1.05
2.7
3.7
17.1
33.0
ng/l
2.35
37
356
48
379
1.37
1.02
3.1
3.2
—
—
—
0
0
9
49
1.88
1.00
1.1
1.1
—
—
—
0
0
22
150
1.54
0.99
3.1
13.0
1.9
1.1
mmol/l
0.32
13
122
0
29
0.00
0.98
0.0
3.3
—
30.9
—
0
13
0
30
0.00
0.98
0.0
3.3
—
4.7
—
0
30
0
30
0.00
0.98
0.0
3.9
—
59.0
—
0
30
29
385
0.70
0.94
2.2
2.9
0.2
0.6
e6/l
1.24
23
279
14
86
1.69
0.94
1.7
10.5
—
—
—
0
0
38
293
1.38
0.93
1.5
1.5
21.2
21.9
nmol/l
0.12
32
244
16
104
1.60
0.88
1.6
1.4
—
—
—
0
0
6
30
2.04
0.88
1.2
1.5
—
—
—
0
0
144
1357
1.44
0.86
4.6
4.4
1.4
1.5
mmol/l
2.14
131
1252
34
431
0.73
0.83
2.1
2.4
—
—
—
0
0
39
482
0.75
0.80
2.6
3.6
10.7
44.2
e6/l
3.04
29
329
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
10
59
1.74
0.77
3.1
2.4
—
—
—
0
0
55
461
1.29
0.77
5.9
4.8
2.4
1.9
ug/l
0.40
48
411
32
248
1.36
0.76
1.3
1.2
17.2
27.7
iu/ml
—
10
78
42
340
1.31
0.76
1.2
1.3
0.9
1.4
u/ml
—
9
97
77
679
1.25
0.70
5.4
4.8
0.0
0.0
estimate
—
9
134
78
689
1.25
0.70
3.9
3.5
0.0
0.0
estimate
—
8
122
33
407
0.76
0.66
2.3
3.1
11.8
197.3
e6/l
0.60
24
306
5
28
1.81
0.66
1.2
1.3
—
—
—
0
0
6
104
0.56
0.64
1.0
1.4
—
—
—
0
0
0
20
0.00
0.61
0.0
2.1
—
—
—
0
0
0
21
0.00
0.60
0.0
3.7
—
—
—
0
0
78
698
1.22
0.60
4.1
5.7
0.2
0.2
e9/l
0.63
71
613
0
22
0.00
0.60
0.0
4.0
—
—
—
0
0
46
535
0.81
0.57
2.2
2.1
—
—
—
0
0
8
55
1.48
0.57
1.8
1.5
—
—
—
0
0
13
181
0.69
0.56
1.5
1.3
—
—
—
0
0
46
393
1.24
0.54
3.3
2.8
—
—
—
0
0
6
97
0.60
0.54
1.0
2.0
—
—
—
0
0
37
309
1.25
0.53
2.1
2.2
2.7
3.0
mg/l
0.56
31
263
52
452
1.22
0.52
2.5
3.4
2.3
2.4
mmol/l
0.32
46
393
7
109
0.63
0.50
6.4
11.4
—
—
—
0
0
86
789
1.19
0.48
6.5
9.3
4.2
4.1
e9/l
0.07
79
682
8
119
0.66
0.47
5.0
4.5
—
—
—
0
0
13
94
1.42
0.47
1.0
1.2
—
37.1
—
0
6
7
49
1.45
0.46
1.3
1.5
24.2
20.7
iu/l
—
7
39
13
171
0.74
0.42
1.5
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
137
1317
1.22
0.41
3.9
4.0
1.4
1.3
mmol/l
1.11
123
1208
40
347
1.20
0.41
3.1
4.4
—
—
—
0
0
0
17
0.00
0.41
0.0
2.1
—
—
—
0
0
26
310
0.81
0.40
1.3
1.4
2.3
2.5
g/l
0.21
20
182
11
146
0.74
0.38
1.5
1.8
—
—
—
0
0
24
283
0.82
0.34
1.4
2.0
—
—
—
0
0
33
287
1.19
0.33
1.3
1.7
1.0
1.5
mg/l
0.70
21
224
30
344
0.84
0.32
4.0
6.8
—
—
—
0
0
7
53
1.33
0.31
1.3
1.4
—
—
—
0
0
34
383
0.86
0.29
4.9
4.0
—
—
—
0
0
47
516
0.88
0.29
3.1
2.7
—
—
—
0
0
12
95
1.28
0.27
2.1
2.2
—
—
—
0
0
12
147
0.80
0.24
1.1
1.4
—
—
—
0
0
5
38
1.33
0.23
3.0
1.9
2.9
5.9
iu/l
—
5
14
7
91
0.76
0.23
4.0
2.9
5.0
5.2
kpa
—
7
85
5
40
1.26
0.22
1.0
1.3
0.2
0.2
g/l
—
5
40
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
10
80
1.27
0.21
1.1
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
3.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
528.7
—
0
7
6
48
1.26
0.20
1.3
1.7
210.0
345.2
mu/l
—
6
43
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
6
50
1.21
0.20
2.7
4.7
—
—
—
0
0
24
269
0.87
0.20
3.2
3.0
1.0
0.7
ug/l
0.45
12
176
10
122
0.81
0.20
1.4
1.4
—
—
—
0
0
40
370
1.11
0.18
4.2
3.6
0.0
0.0
estimate
—
9
131
8
70
1.15
0.16
6.9
3.4
—
—
—
0
0
7
86
0.81
0.15
6.1
8.6
25.1
25.2
mmol/l
—
7
86
13
147
0.87
0.12
1.3
1.3
—
—
—
0
0
70
675
1.06
0.11
4.4
5.4
0.0
0.0
e9/l
0.04
65
579
11
124
0.88
0.09
1.2
1.3
—
—
—
0
0
42
401
1.06
0.09
1.3
1.4
—
—
—
0
0
6
57
1.05
0.08
1.5
1.7
—
—
—
0
0
13
117
1.12
0.08
3.4
4.5
—
—
—
0
0
9
83
1.09
0.07
1.1
1.3
—
—
—
0
0
53
513
1.05
0.07
4.4
3.3
—
—
—
0
0
11
100
1.11
0.05
2.1
3.5
—
—
—
0
0
26
272
0.95
0.05
1.5
2.4
2.6
4.9
e6/l
0.97
21
244
17
161
1.06
0.03
1.3
1.5
—
—
—
0
0
31
319
0.97
0.02
4.5
3.3
—
—
—
0
0
31
304
1.02
0.00
3.8
4.9
—
—
—
0
0
17
166
1.03
0.00
1.1
1.6
—
—
—
0
0
12
119
1.01
0.00
2.8
3.6
—
—
—
0
0
22
219
1.01
0.00
1.3
1.6
—
—
—
0
0
23
232
0.99
0.00
2.0
3.4
0.8
0.8
mmol/l
0.50
23
220
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
1.5
—
0
5
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
5.2
—
43.2
—
0
5
5
59
0.84
0.00
1.2
1.4
—
—
—
0
0
5
57
0.87
0.00
1.4
1.4
—
—
—
0
0
5
59
0.84
0.00
1.4
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
12.7
—
0
6
8
89
0.89
0.00
1.6
1.6
1.6
1.1
g/l
—
8
80
0
6
0.00
0.00
0.0
1.8
—
1965.8
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
0.00
1.3
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
5
58
0.86
0.00
1.4
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
3.8
9.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
12.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
11.2
—
1198.1
—
0
9
0
9
0.00
0.00
0.0
14.4
—
2260.3
—
0
9
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
34.7
—
95.2
—
0
6

Mortality – FinRegistry

Association

Association between endpoint H8_MYRINGCHRON and mortality.

Females

Parameter HR [95% CI] p-value
H8_MYRINGCHRON 0.971 [0.69, 1.37] 0.867
Birth year 0.995 [0.99, 1.0] 0.274

During the follow-up period (1.1.1998 — 31.12.2019), 51 out of 610 females with H8_MYRINGCHRON died.

Males

Parameter HR [95% CI] p-value
H8_MYRINGCHRON 0.866 [0.64, 1.18] 0.359
Birth year 0.987 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 53 out of 607 males with H8_MYRINGCHRON died.

Mortality risk

Mortality risk for people of age

years, who have H8_MYRINGCHRON.

N-year risk Females Males
1 0.117% 0.183%
5 0.575% 0.998%
10 1.505% 2.504%
15 2.861% 4.861%
20 4.939% 8.169%

Relationships between endpoints

Index endpoint: H8_MYRINGCHRON – Chronic myringitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data